[Skip to Navigation]
Sign In
Comment & Response
June 9, 2021

Comments and Concerns on the LASER Trial

Author Affiliations
  • 1Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada
  • 2Department of Surgery, St Michael’s Hospital, Unity Health Toronto, Toronto, Ontario, Canada
JAMA Surg. 2021;156(10):985-986. doi:10.1001/jamasurg.2021.2250

To the Editor In clinical trial design, the minimal clinically important difference (MCID) is used in sample size calculations to ensure enough statistical power to detect the smallest difference needed to justify changing patient treatment. Unfortunately, because these calculations are based on probabilities of hypothetical findings, clinical trials can produce statistically significant results for differences smaller than those considered clinically important. To avoid implementing changes based on statistical differences that are not clinically meaningful, it is important to consider if the MCID falls within the 95% CI of the effect estimate.1

Add or change institution